Log in
Enquire now

List of Heron Therapeutics patents

List of Heron Therapeutics patents
List of NEONC Technologies patents
List of Parse (company) patents
List of Contipro patents
List of awards received by Kanye West
List of companies in EGirl Capital's investment portfolio
Patents where
Current Assignee
Name
is
Heron TherapeuticsHeron Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9694079 Long-acting polymeric delivery systems

Patent 9694079 was granted and assigned to Heron Therapeutics on July, 2017 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9694079
July 4, 2017
‌
US Patent 11413350 Long-acting polymeric delivery systems

Patent 11413350 was granted and assigned to Heron Therapeutics on August, 2022 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11413350
August 16, 2022
‌
US Patent 11744800 Methods of use of emulsion formulations of an NK-1 receptor antagonist

Patent 11744800 was granted and assigned to Heron Therapeutics on September, 2023 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11744800
September 5, 2023
‌
US Patent 11878074 Methods of use of emulsion formulations of an NK-1 receptor antagonist

Patent 11878074 was granted and assigned to Heron Therapeutics on January, 2024 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11878074
January 23, 2024
‌
US Patent 12115255 Methods of use of emulsion formulations of an NK-1 receptor antagonist

Patent 12115255 was granted and assigned to Heron Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
12115255
October 15, 2024
‌
US Patent 9561229 Emulsion formulations of aprepitant

Patent 9561229 was granted and assigned to Heron Therapeutics on February, 2017 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9561229
February 7, 2017
‌
US Patent 9808465 Emulsion formulations of aprepitant

Patent 9808465 was granted and assigned to Heron Therapeutics on November, 2017 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9808465
November 7, 2017
‌
US Patent 9913910 Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

Patent 9913910 was granted and assigned to Heron Therapeutics on March, 2018 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9913910
March 13, 2018
‌
US Patent 9592227 Compositions of a polyorthoester and an aprotic solvent

Patent 9592227 was granted and assigned to Heron Therapeutics on March, 2017 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9592227
March 14, 2017
‌
US Patent 10357570 Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

Patent 10357570 was granted and assigned to Heron Therapeutics on July, 2019 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10357570
July 23, 2019
‌
US Patent 9801945 Long-acting polymeric delivery systems

Patent 9801945 was granted and assigned to Heron Therapeutics on October, 2017 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9801945
October 31, 2017
‌
US Patent 9913909 Compositions of a polyorthoester and an aprotic solvent

Patent 9913909 was granted and assigned to Heron Therapeutics on March, 2018 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9913909
March 13, 2018
‌
US Patent 9446036 Compositions of a polyorthoester and an aprotic solvent

Patent 9446036 was granted and assigned to Heron Therapeutics on September, 2016 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9446036
September 20, 2016
‌
US Patent 9744163 Compositions of a polyorthoester and an aprotic solvent

Patent 9744163 was granted and assigned to Heron Therapeutics on August, 2017 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9744163
August 29, 2017
‌
US Patent 8715710 Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

Patent 8715710 was granted and assigned to Heron Therapeutics on May, 2014 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8715710
May 6, 2014
‌
US Patent 12115254 Methods of use of emulsion formulations of an NK-1 receptor antagonist

Patent 12115254 was granted and assigned to Heron Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
Heron Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
12115254
October 15, 2024
16 results
0 selected
16 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us